Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Observational Study to Evaluate the Long-Term Safety of Subcutaneous Injections of Palynziq® (Pegvaliase) in Subjects With Phenylketonuria

NCT05813678 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT05813678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05813678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Observational Study to Evaluate the Long-Term Safety of Subcutaneous Injections of Palynziq® (Pegvaliase) in Subjects With Phenylketonuria
Lead sponsor
BioMarin Pharmaceutical
Phase
Observational
Overall status
Recruiting
Start date
June 6, 2022
Completion date
November 1, 2033
Enrollment
450 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonuria (pku)